Market news

Teladoc (TDOC) reached $5.75 at the closing of the latest trading day, reflecting a -2.38% change compared to its last close.

A number of stocks fell in the afternoon session after the benchmark U.S. 10-year Treasury yield climbed back above 5% to levels not seen since 2007, lifting discount rates on long-duration growth earnings. According to CNBC, the 10-year yield surged to 5.23% on Friday, its highest level since 2007, after trading below 4.8% earlier in September. CNBC reported Monday that the yield was again pressing multiyear highs — above 5.23% in morning trade — as oil stayed elevated and investors braced for

Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.

Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 Jonathan Dorfman Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026. NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer and Secretary, has informed the company o

Teladoc (TDOC) closed the most recent trading day at $6.13, moving 3.46% from the previous trading session.

Earlier this week, Teladoc Health reported quarterly results showing a 4% year-on-year revenue decline, missing analyst expectations on both revenue and EBITDA and issuing guidance for the next quarter that also fell short of forecasts. The results highlighted a 9.2% average drop in customer spending over recent years despite user growth, alongside expectations for another period of lower revenue and negative earnings per share, underscoring pressure on Teladoc’s core business model. Now...

Teladoc (TDOC) concluded the recent trading session at $6.28, signifying a -2.33% move from its prior day's close.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Teladoc (NYSE:TDOC) and the best and worst performers in the online marketplace industry.

Teladoc (TDOC) reached $6.16 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.

Don't catch a falling knife.

Motley Fool Press Release.

Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to a new employee. Effective September 1, 2026, in connection with commencing employment as Chief Financial Officer, Michael Grasher was granted an award of restricted stock units covering 239,616 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and awards of performance stock units covering a targe

Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.

Aug 31 () - Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing ‌in an industry veteran to help the virtual healthcare ‌company navigate rising demand for its insurance-covered business. Here are some more details: • The ​appointment comes about a month after Teladoc cut its annual revenue forecast and flagged challenges at its mental health services unit BetterHelp, where growing demand for insurance-covered therapy has outpaced the ‌company's ava

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Teladoc Health (TDOC) is back in focus after long serving director David B. Snow Jr. notified the company on August 10, 2026 of his plan to retire from the board on September 30. See our latest analysis for Teladoc Health. At a share price of US$6.20, Teladoc Health has seen its 30 day share price return fall 29.3%, while the 1 year total shareholder return is down 19.2%. This points to fading momentum as investors weigh execution risks around BetterHelp and wider virtual care demand. If this...

TDOC's BetterHelp faces a capacity crunch as insurance demand surges, putting therapist recruitment and credentialing at the center.

BetterHelp remains Teladoc’s biggest headache as customers shift toward insurance-covered therapy and provider capacity struggles to keep up.

The 5 Most Interesting Analyst Questions From Teladoc’s Q2 Earnings Call

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former president and chief operating officer of Verisk Analytics, a strategic data analytics and technology partner to the global insurance industry. He will serve on the board’s Audit & Compensation committees. “Mark’s leadership across the global insurance and analytics sectors, along w

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Teladoc Health (TDOC) shares came under focus after the company reported second quarter 2026 results, which showed lower sales and a wider net loss, alongside fresh revenue and earnings guidance for the rest of the year. See our latest analysis for Teladoc Health. The earnings release and updated guidance appear to be weighing heavily on sentiment. Teladoc Health's share price return is down 28.32% over the past day and 24.02% over the past week, while the 1-year total shareholder return has...

TDOC tops adjusted earnings estimates despite a revenue miss, as Integrated Care and international growth help cushion BetterHelp weakness and a lower 2026 outlook.

Teladoc Health (TDOC) reported a Q2 loss late Wednesday of $0.21 per diluted share, wider than a los

Teladoc stock sinks on disappointing Q2 revenue and future guidance. Here’s why caution is warranted in buying the dip in TDOC shares today.

Demand for the mental health unit’s insurance offering accelerated faster than expected, eating into its cash pay business. The quarter marked an “unfortunate setback” for BetterHelp, one analyst said.

Teladoc Health (NYSE:TDOC) reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at BetterHelp prompted the company to reduce its full-year revenue outlook. Consolidated

These are the stocks posting the largest moves in the premarket.

Moby summary of Teladoc Health, Inc.'s Q2 2026 earnings call

Teladoc (TDOC) delivered earnings and revenue surprises of +12.50% and -1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

In late July 2026, Teladoc Health, Inc. reported second-quarter 2026 results showing sales of US$606.93 million and a net loss of US$38.91 million, with both revenue and per-share loss slightly weaker than the same period a year earlier. Over the first half of 2026, Teladoc’s sales declined to US$1.22 billion while its net loss narrowed to US$102.75 million, indicating that cost controls and efficiency measures may be helping even as top-line growth remains under pressure. We will now...

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2025 (“Second Quarter 2025”). Highlights Second Quarter 2026 revenue of $606.9 million, down 4% year-over-yearSecond Quarter 2026 net loss of $38.9 million, or $0.21 per shareSecond Quar

Digital medical services platform Teladoc Health (NYSE:TDOC) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 4% year on year to $606.9 million. Next quarter’s revenue guidance of $589 million underwhelmed, coming in 6.5% below analysts’ estimates. Its GAAP loss of $0.21 per share was 17.4% above analysts’ consensus estimates.